Key result
High-risk AF patients are no more likely to receive warfarin or aspirin than moderate-risk patients.
Why the study?
The annual stroke rate in atrial fibrillation is around 5 percent with increased risk in patients with modifiable cardiovascular risk factors, but identification and management of these patients remain suboptimal.
Cross-Sectional (n=944)
Yes
This cross-sectional study highlights significant gaps in real-world stroke prevention for atrial fibrillation, demonstrating underutilization of anticoagulation and suboptimal blood pressure control.
No takes yet. Share an insight, caveat, or question.
Supports AF risk-factor screening in primary care but remains hypothesis-generating; leaves open whether modification alters stroke incidence.
Lusignan et al. (2004) conducted a cross-sectional in Atrial fibrillation (n=944). Atrial fibrillation and modifiable stroke risk factors was evaluated on Prevalence of atrial fibrillation and management of stroke risk factors. Among 944 patients with atrial fibrillation, 25% of men and 31% of women had BP >150/90, and high-risk patients were no more likely to receive Warfarin or aspirin than moderate-risk patients.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: